NCT01537926View on ClinicalTrials.gov

Hypertrophic Regression With N-Acetylcysteine in HCM

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Hypertrophic Cardiomyopathy
Interventions
DRUG

N-acetylcysteine

NAC 600mg capsule or matching Placebo , 1 twice daily for 90 days, then increase to NAC 1,200mg or matching placebo, 2 capsules twice daily for 270 days.

DRUG

Placebo

sugar pill manufactured to minic NAC 600mg capsule

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

The University of Texas Health Science Center, Houston

OTHER

NCT01537926 - Hypertrophic Regression With N-Acetylcysteine in HCM | Biotech Hunter | Biotech Hunter